Table 2.
Item | Treatments1 |
SEM2 | P-value | ||||
---|---|---|---|---|---|---|---|
PC | NC | FA | P1 | P2 | |||
BW at d 0, kg | 7.42 | 7.41 | 7.41 | 7.42 | 7.41 | 0.06 | 0.99 |
Day 0 to 7 | |||||||
ADG, g | 449 | 482 | 478 | 457 | 527 | 30.3 | 0.44 |
ADFI, g | 697 | 710 | 725 | 666 | 772 | 36.7 | 0.41 |
G:F | 0.65 | 0.68 | 0.67 | 0.69 | 0.68 | 0.03 | 0.86 |
Day 7 to 14 | |||||||
ADG, g | 488 | 356 | 396 | 478 | 504 | 34.2 | 0.04 |
ADFI, g | 800 | 623 | 713 | 710 | 799 | 42.5 | 0.05 |
G:F | 0.61ab | 0.56b | 0.55b | 0.68a | 0.63ab | 0.02 | <0.01 |
Day 14 to 21 | |||||||
ADG, g | 477ab | 394b | 421b | 499ab | 545a | 31.8 | 0.02 |
ADFI, g | 856 | 760 | 808 | 851 | 917 | 42.5 | 0.16 |
G:F | 0.56 | 0.53 | 0.52 | 0.58 | 0.60 | 0.03 | 0.17 |
Day 7 to 21 | |||||||
ADG, g | 483 | 390 | 424 | 486 | 521 | 27.1 | 0.08 |
ADFI, g | 828 | 696 | 785 | 781 | 858 | 42.1 | 0.13 |
G:F | 0.58 | 0.56 | 0.54 | 0.63 | 0.62 | 0.02 | 0.07 |
Day 0 to 21 | |||||||
ADG, g | 471 | 421 | 446 | 476 | 512 | 39.9 | 0.40 |
ADFI, g | 784 | 707 | 789 | 732 | 830 | 39.9 | 0.22 |
G:F | 0.60 | 0.59 | 0.56 | 0.65 | 0.62 | 0.02 | 0.09 |
BW = body weight; ADG = average daily gain; ADFI = average daily feed intake; G:F = gain-to-feed ratio.
a,b Different superscripts within a row indicate a significant difference (P < 0.05).
PC, non-challenged positive control; NC, enterotoxigenic Escherichia coli F4 (K88+)-challenged (on d 7) negative control; FA, NC + kitasamycin at 50 mg/kg + olaquindox at 100 mg/kg + regular free acids at 5 g/kg; P1, NC + kitasamycin at 50 mg/kg + olaquindox at 100 mg/kg + micro-encapsulated combination of organic acids and essential oils at 1 g/kg; P2, NC + kitasamycin at 50 mg/kg + olaquindox at 100 mg/kg + micro-encapsulated combination of organic acids and essential oils at 2 g/kg.
SEM means standard error of the means (n = 6).